Results 191 to 199 of about 13,098 (199)

KMT2D inhibits the growth and metastasis of bladder Cancer cells by maintaining the tumor suppressor genes

Biomedicine and Pharmacotherapy, 2019
Zilian Cui, Dong Zhang, Qing-Hua Xia
exaly  

Linking KMT2D to ASD

Lab Animal
openaire   +2 more sources

MiRNA-217 accelerates the proliferation and migration of bladder cancer via inhibiting KMT2D

Biochemical and Biophysical Research Communications, 2019
Zhiyong Li, Yabin Jin, Jialing Wu
exaly  

Clinical and Neurobehavioral Features of Three Novel Kabuki Syndrome Patients with Mosaic KMT2D Mutations and a Review of Literature

International Journal of Molecular Sciences, 2018
Giuseppe Merla, Bartolomeo Augello, Stefano Sotgiu   +2 more
exaly  

INHIBITION OF KMT2D FOR THE TREATMENT OF CANCER

2018
BASELGA JOSE, TOSKA ENEDA, ARMSTRONG SCOTT   +2 more
openaire   +3 more sources

Critical Roles of the Histone Methyltransferase MLL4/KMT2D in Murine Hepatic Steatosis Directed by ABL1 and PPARγ2

Cell Reports, 2016
Seunghee Lee, Jae Lee, Dae-Hwan Kim
exaly  

Mechanistic insights into the role of KMT2D in Kabuki syndrome 1

Kabuki syndrome type 1 (KS1) is a Mendelian disorder of the epigenetic machinery (MDEM) caused by heterozygous pathogenic variants in the histone methyltransferase 2 D (KMT2D). KS is a multi-organ disorder with variable phenotypic presentations among different individuals.
openaire   +1 more source

Mechanism of KMT2D-mediated epigenetic modification in IL-1β-induced nucleus pulposus cell degeneration.

Histology and Histopathology
Hongjian Liu, Haiquan Liu, Zuyu Meng, Wensheng Zhang   +3 more
semanticscholar   +1 more source

METHODS AND COMPOSITIONS FOR THE TREATMENT OF KMT2D-DEFICIENT CANCERS

LEE MIN, DHAR SHILPA
openaire   +1 more source